POLYMORPHISM OF APOLIPOPROTEIN-A-II (APOA-II) AMONG INBRED STRAINS OF MICE - RELATIONSHIP BETWEEN THE MOLECULAR TYPE OF APOA-II AND MOUSE SENILE AMYLOIDOSIS

被引:90
作者
HIGUCHI, K [1 ]
KITAGAWA, K [1 ]
NAIKI, H [1 ]
HANADA, K [1 ]
HOSOKAWA, M [1 ]
TAKEDA, T [1 ]
机构
[1] FUKUI MED SCH,DEPT PATHOL,FUKUI 91011,JAPAN
关键词
D O I
10.1042/bj2790427
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Three types of apolipoprotein A-II (apoA-II) proteins (A, B and C) were predicted from the nucleotide sequence of apoA-II cDNA. Substitution of amino acid residues was noted at four positions (type A: Pro-5, Asp-20, Met-26, Ala-38; B: Pro-5, Glu-20, Val-26, Val-38; C: Gln-5, Glu-20, Val-26, Ala-38). Each type was identifiable by digestion of amplified apoA-II DNA by PCR, using restriction-fragment-length polymorphism of the apoA-II gene for restriction enzymes (Cfr13I and MspI. The molecular type of apoA-II was determined among 23 strains of mice including nine of the senescence accelerated mouse series developed in our laboratory. Examination of types of apoA-II and amyloid deposition in the F2 and F3 hybrid mice showed that apoA-II amyloid deposition was present only in the mice homozygous for type C apoA-II and which were 12-17 months of age. The molecular type of apoA-II may be a factor involved in the development of senile amyloidosis in mice.
引用
收藏
页码:427 / 433
页数:7
相关论文
共 36 条
[1]  
ANANTHARAMAIAH GM, 1988, J LIPID RES, V29, P309
[2]  
CHEN WH, 1989, AM J PATHOL, V135, P379
[3]   EVIDENCE THAT THE AMYLOID FIBRIL PROTEIN IN SENILE SYSTEMIC AMYLOIDOSIS IS DERIVED FROM NORMAL PREALBUMIN [J].
CORNWELL, GG ;
SLETTEN, K ;
JOHANSSON, B ;
WESTERMARK, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 154 (02) :648-653
[4]  
DOOLITTLE MH, 1990, J BIOL CHEM, V265, P16380
[5]  
Glenner G G, 1976, Int Rev Exp Pathol, V15, P1
[6]   SYSTEMIC SENILE AMYLOIDOSIS - IDENTIFICATION OF A NEW PREALBUMIN (TRANSTHYRETIN) VARIANT IN CARDIAC TISSUE - IMMUNOLOGICAL AND BIOCHEMICAL SIMILARITY TO ONE FORM OF FAMILIAL AMYLOIDOTIC POLYNEUROPATHY [J].
GOREVIC, PD ;
PRELLI, FC ;
WRIGHT, J ;
PRAS, M ;
FRANGIONE, B .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (03) :836-843
[7]  
Green MC., 1989, GENETIC VARIANTS STR, P12
[8]  
HIGUCHI K, 1983, LAB INVEST, V48, P231
[9]  
HIGUCHI K, 1986, J BIOL CHEM, V261, P2834
[10]   THE SINGLE PROLINE-GLUTAMINE SUBSTITUTION AT POSITION-5 ENHANCES THE POTENCY OF AMYLOID FIBRIL FORMATION OF MURINE APO A-II [J].
HIGUCHI, K ;
YONEZU, T ;
TSUNASAWA, S ;
SAKIYAMA, F ;
TAKEDA, T .
FEBS LETTERS, 1986, 207 (01) :23-27